Health1 min read

Genetic testing subsidies for hereditary breast, ovarian cancer to start on Dec 1

By · Published by Everything Blog

In short

The new initiative offers eligible patients up to 70 per cent subsidies for specialized genetic tests typically priced around S$1,000, with remaining sums payable via MediSave balances. An estimated 2,000 individuals each year are expected to benefit from the support, which also extends to cascade testing for first-degree relatives of identified mutation carriers. Services will be accessible through specialist outpatient clinics at the National Cancer Centre Singapore, National University Cancer Institute Singapore, and Tan Tock Seng Hospital. Health authorities hope this broadened access will avert healthcare disparities and facilitate timely preventive medical measures.

Key points

  • The Ministry of Health expects the newly introduced testing subsidies to benefit approxim…: The Ministry of Health expects the newly introduced testing subsidies to benefit approximately 2,000 people each year.
  • Carrying mutations in genes like BRCA1 and BRCA2 increases a woman's lifetime risk of bre…: Carrying mutations in genes like BRCA1 and BRCA2 increases a woman's lifetime risk of breast or ovarian cancer by five to ten times.
  • Identifying high-risk gene variants enables families to adopt critical safeguards such as…: Identifying high-risk gene variants enables families to adopt critical safeguards such as routine mammograms, MRI scans, or preventive surgeries.

Sources checked by our analysis pipeline: 1

About 2,000 people are expected to benefit each year, with doctors saying the subsidies could help more families identify hereditary risks early and take preventive action.

SINGAPORE: When Ms Norain Mohamad Saleh was diagnosed with breast cancer at 37, she underwent genetic testing that revealed she carries a hereditary gene mutation linked to a higher risk of cancer.

The results helped her younger sister better understand her own risk of developing cancer and take steps towards early detection and preventive care.

From Dec 1, such testing will become more affordable, with eligible patients receiving subsidies of up to 70 per cent for hereditary breast and ovarian cancer (HBOC) genetic testing.

First announced by the Ministry of Health (MOH) in March, the subsidies will be available at specialist outpatient clinics at the National Cancer Centre Singapore (NCCS), National University Cancer Institute Singapore and Tan Tock Seng Hospital.

MOH estimates that about 2,000 people could benefit each year from the subsidised genetic testing.

The test costs about S$1,000 (US$782) before subsidies, with patients who have sufficient MediSave balances able to use them…

Health